Christian Brechot, MD, Ph.D., is a Professor in the Morsani College of Medicine and Senior Associate Dean for Research on Global Affairs and Associate Vice President for International Partnerships and Innovation at the University of South Florida. Prior, he was President of the Global Virus Network (2017 - 2023); he is now serving as Vice-Chair of the board and Emeritus President. His career has been entirely focused on science, medicine and public health, combining a high profile in basic and translational research in academic and industrial settings, as well as teaching and high-level research administration in an international context. His research expertise is based on combining molecular and cellular biology, virology, hepatology and oncology. More recently, he has been investigating the role of a C-type lectin (Reg3A/HIP) in resistance to insulin, diabetic neuropathy and Alzheimers diseases. He studied molecular biology, virology, and cellular biology at the laboratory of Pierre Tiollais at the Pasteur Institute, and at the Necker School of Medicine (Paris Descartes University); he obtained his PhD in biochemistry from the University of Paris VII. In 1989, he became full professor of Cell Biology and Hepatology at Paris Descartes University and in 1997 he was appointed head of the clinical department of liver diseases at the Necker-Enfants Malades Hospital. He served as the General Director of Inserm, the French National Agency for biomedical research (French NIH) from 2001 to 2007. In 2008, he was appointed as Vice-President of Medical and Scientific Affairs of the Institut Merieux company, and from 2013 - 2017 he served as President of the Institut Pasteur. He has been a member of numerous scientific committees and societies and has received prestigious awards. Dr. Brechot is the author of over 400 articles published in medical and scientific journals with a current H factor of over 100. His research activities have led him to obtain 18 patents and to contribute to the creation of three biotech companies: Rarecells, ALFACT Innovation and he is the founder and chairman of the Healthy Aging Company.